These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 30404981)
1. Repurposing of Approved Cardiovascular Drugs against Ischemic Cerebrovascular Disease by Disease-Disease Associated Network-Assisted Prediction. Zhao QQ; Li X; Luo LP; Qian Y; Liu YL; Wu HT Chem Pharm Bull (Tokyo); 2019 Jan; 67(1):32-40. PubMed ID: 30404981 [TBL] [Abstract][Full Text] [Related]
2. Drug repurposing for drug development in stroke. Fagan SC Pharmacotherapy; 2010 Jul; 30(7 Pt 2):51S-4S. PubMed ID: 20575622 [TBL] [Abstract][Full Text] [Related]
5. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease. Shoaib M; Kamal MA; Rizvi SMD Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531 [TBL] [Abstract][Full Text] [Related]
8. Deciphering the pharmacological mechanism of the Chinese formula huanglian-jie-du decoction in the treatment of ischemic stroke using a systems biology-based strategy. Zhang YQ; Wang SS; Zhu WL; Ma Y; Zhang FB; Liang RX; Xu HY; Yang HJ Acta Pharmacol Sin; 2015 Jun; 36(6):724-33. PubMed ID: 25937634 [TBL] [Abstract][Full Text] [Related]
10. Drug repurposing for stroke intervention. Ghosh D; Sehgal K; Sodnar B; Bhosale N; Sarmah D; Datta A; Chaudhary A; Kalia K; Wang X; Bhattacharya P Drug Discov Today; 2022 Jul; 27(7):1974-1982. PubMed ID: 35257857 [TBL] [Abstract][Full Text] [Related]
11. A computational approach to drug repurposing using graph neural networks. Doshi S; Chepuri SP Comput Biol Med; 2022 Nov; 150():105992. PubMed ID: 36228466 [TBL] [Abstract][Full Text] [Related]
12. Systems pharmacology strategies for drug discovery and combination with applications to cardiovascular diseases. Li P; Chen J; Wang J; Zhou W; Wang X; Li B; Tao W; Wang W; Wang Y; Yang L J Ethnopharmacol; 2014; 151(1):93-107. PubMed ID: 23850710 [TBL] [Abstract][Full Text] [Related]
13. Network pharmacology-based prediction and verification of the molecular targets and pathways for schisandrin against cerebrovascular disease. Lv YN; Li SX; Zhai KF; Kou JP; Yu BY Chin J Nat Med; 2014 Apr; 12(4):251-8. PubMed ID: 24863349 [TBL] [Abstract][Full Text] [Related]
15. Inferring new indications for approved drugs via random walk on drug-disease heterogenous networks. Liu H; Song Y; Guan J; Luo L; Zhuang Z BMC Bioinformatics; 2016 Dec; 17(Suppl 17):539. PubMed ID: 28155639 [TBL] [Abstract][Full Text] [Related]
16. A weighted and integrated drug-target interactome: drug repurposing for schizophrenia as a use case. Huang LC; Soysal E; Zheng W; Zhao Z; Xu H; Sun J BMC Syst Biol; 2015; 9 Suppl 4(Suppl 4):S2. PubMed ID: 26100720 [TBL] [Abstract][Full Text] [Related]